A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 23
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : BTAs
Long Form : bone-targeted agents
No. Year Title Co-occurring Abbreviation
2020 A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer. CRPC, EORTC, HRQoL, SSEs
2020 Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases. BESM, BOM, mCRPC, SREs, SSEs
2020 Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16). ---
2020 Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer. SREs
2020 Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer. BC, BM
2019 A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe. BMs, PROs, QOL, SREs
2019 Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States. SREs
2019 Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers? ---
2019 Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US. CRPC, SREs
10  2019 Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. ONJ
11  2018 Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries. BMs, PROs, QOL, SREs
12  2018 Cancer Treatment and Bone Health. CTIBL
13  2018 Osteonecrosis of the jaw (ONJ) in patients who receive Bone Targeting Agents (BTAs): the power of e-learning. ONJ
14  2018 Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom. ONJ, SREs
15  2018 Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States. CI
16  2017 The role of bone-targeted therapies for prostate cancer in 2017. mCRPC, OS, PCa, SREs
17  2016 A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer. ---
18  2016 Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors. SREs
19  2015 Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options. mCRPC, PCa, SREs
20  2015 Physician preferences for bone metastasis drug therapy in Canada. ONJ, SREs
21  2015 Validation of International Classification of Diseases coding for bone metastases in electronic health records using technology-enabled abstraction. CI, EHR, NPV, PPV
22  2014 Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US. IV-BP, OSCER, RANK
23  2013 Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey. ---